Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

GSTZ1 – Maleylacetoacetate Isomerase Deficiency

Biallelic splice variant c.136-2A>G in GSTZ1 was identified in one neonate after newborn screening for hepatorenal tyrosinemia type I in a cohort of 516 803 infants, with segregation analysis revealing maternal heterozygosity and paternal homozygosity; the father remained asymptomatic at age 32 (PMID:38535121). The lack of clinical or laboratory abnormalities in a homozygous adult over three decades disputes a pathogenic role for GSTZ1 in maleylacetoacetate isomerase deficiency. Key Take-home: GSTZ1 variants detected during HT1 screening may represent benign findings and warrant careful clinical interpretation.

References

  • • • Newborn screening for hepatorenal tyrosinemia type I reveals benign maleylacetoacetate isomerase deficiency PMID:38535121

Evidence Based Scoring (AI generated)

Gene–Disease Association

Disputed

Single family with one proband and unaffected homozygous parent over 32 years indicates lack of clinical phenotype (PMID:38535121)

Genetic Evidence

Limited

Only one biallelic case reported and no affected relatives segregating disease

Functional Evidence

Limited

No functional studies on the splice variant; existing enzyme polymorphism data not linked to clinical phenotype